What is Teknova?
Founded in 1996 and headquartered in Hollister, California, Teknova is a key provider of critical reagents essential for bioprocessing, bioproduction, and molecular diagnostics. The company's comprehensive product portfolio includes cell culture media and supplements, protein purification buffers, and molecular biology reagents, serving the dynamic needs of the life sciences and healthcare communities. This strategic positioning allows Teknova to support advancements in drug discovery, development, and diagnostic testing.
How much funding has Teknova raised?
Teknova has raised a total of $96M across 1 funding round:
Stock Offering
$96M
Stock Issuance/Offering (2021): $96M, investors not publicly disclosed
What's next for Teknova?
The recent major strategic investment in Teknova signals a strong vote of confidence in its growth trajectory and market potential. This capital infusion is expected to fuel further innovation in its reagent offerings, potentially expanding its manufacturing capabilities and market reach. Teknova is poised to leverage this financing to solidify its position as a leading supplier of essential components for biopharmaceutical development and molecular diagnostics, driving forward critical research and production efforts.
See full Teknova company page
